D-0628-2026 Class II Ongoing
FDA drug recall D-0628-2026 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jun 17, 2026 and is designated Class II. Reason for recall: Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets. The recall status is ongoing. Affected quantity: 3,456 30-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 1, 2026
- Initiation Date
- Jun 17, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,456 30-count bottles
Product description
Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6
Reason for recall
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
Distribution pattern
Nationwide in the USA
Code information
Lot AE01763, Expires 9/30/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0628-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026